BridgeBio Oncology Therapeutics Inc.
USD7.40
-0.29 (-3.77%)
CEO
Eli Wallace
IPO Date
2025-08-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.68
Prev. Close
$7.69
Day Low
$7.30
Day High
$7.97
52W Low
$7.00
52W High
$14.87
Market Cap
$0.59B
Volume
0.72M
| 31,675 |
| $7.73 |
| 18 Jun 2026 | Lebowitz Peter F | director | A-Award | Acquired | 7,289 | $7.73 |
| 18 Jun 2026 | Kelleher Raymond J. | director | A-Award | Acquired | 31,675 | $7.73 |
| 18 Jun 2026 | Chen Bihua | director, 10 percent owner: | A-Award | Acquired | 31,675 | $7.73 |
| 18 Jun 2026 | Bauer Jake | director | A-Award | Acquired | 31,675 | $7.73 |
| 18 Jun 2026 | Kumar Neil | director | A-Award | Acquired | 31,675 | $7.73 |
| 12 May 2026 | Elmelech Idan | COO & Principal Financial Ofcr | A-Award | Acquired | 758,222 | $7.66 |
| 12 May 2026 | Beltran Pedro | director, officer: President and CEO | A-Award | Acquired | 1,103,837 | $7.66 |
| 5 May 2026 | Ben Yong | Chief Med & Dev Officer | F-InKind | Disposed | 1,047 | $9.03 |